Presence and function of the calcitonin gene-related peptide receptor on rat pial arteries investigated in vitro and in vivo

Cephalalgia

Volumn 25, Issue 6, 2005, Pages 424-432

  Petersen, Kenneth A ^a,b   Nilsson, E ^c   Olesen, J ^a   Edvinsson, L ^b,c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

CGRP receptor; Cortical pial arteries; Endothelium and vascular smooth muscle cells; Middle cerebral artery

Indexed keywords

ADRENOMEDULLIN; ALPHA CALCITONIN GENE RELATED PEPTIDE; AMYLIN; BETA CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOGRAPHY; ARTICLE; BLOOD PRESSURE; BLOOD VESSEL DIAMETER; BRAIN ARTERY; BRAIN CIRCULATION; CONTROLLED STUDY; IN VITRO STUDY; IN VIVO STUDY; MALE; MICROPIPETTE; MICROSCOPY; MIDDLE CEREBRAL ARTERY; MIGRAINE; NONHUMAN; PATHOGENESIS; PIA ARTERY; PROTEIN FUNCTION; RAT; SMOOTH MUSCLE FIBER; VIDEORECORDING;

ADRENOMEDULLIN; AMYLOID; ANGIOGRAPHY; ANIMALS; ARTERIES; CEREBROVASCULAR CIRCULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MUSCLE, SMOOTH, VASCULAR; PEPTIDES; PIA MATER; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CALCITONIN GENE-RELATED PEPTIDE; VASODILATION; VASODILATOR AGENTS;

EID: 20044394766     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2005.00869.x     Document Type: Article

References (34)

1. Amara SG, Jonas V, Rosenfeld MG, Ong ES, Evans RM. Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature 1982; 298 (5871):240-4.
2. Sexton PM. Central nervous system binding sites for calcitonin and calcitonin gene-related peptide. Mol Neurobiol 1991; 5:251-73.
3. Brain SD, Cambridge H. Calcitonin gene-related peptide: vasoactive effects and potential therapeutic role. Gen Pharmacol 1996; 27:607-11.
4. Uddman R, Edvinsson L, Ekblad E, Hakanson R, Sundler F. Calcitonin gene-related peptide (CGRP): perivascular distribution and vasodilatory effects. Regul Pept 1986; 15:1-23.
5. Edvinsson L. Functional role of perivascular peptides in the control of cererbral circulation. Trends Neurosci 1985; 8:126-31.
6. Uddman R, Edvinsson L, Ekman R, Kingman T, McCulloch J. Innervation of the feline cerebral vasculature by nerve fibers containing calcitonin gene-related peptide: trigeminal origin and co-existence with substance P. Neurosci Lett 1985; 62:131-6.
7. Olesen J, Tfelt-Hansen P, Welch K. The headaches. Philadelphia: Lippencott Willians and Wilkins, 2000.
8. Amara SG, Arriza JL, Leff SE, Swanson LW, Evans RM, Rosenfeld MG. Expression in brain of a messenger RNA encoding a novel neuropeptide homologous to calcitonin gene-related peptide. Science 1985; 229 (4718):1094-7.
9. Aiyar N, Rand K, Elshourbagy NA, Zeng Z, Adamou JE, Bergsma DJ et al. A cDNA encoding the calcitonin gene-related peptide type 1 receptor. J Biol Chem 1996; 271:11325-9.
10. McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N et al. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor- like receptor. Nature 1998; 393 (6683):333-9.
11. Foord SM, Marshall FH. RAMPs: accessory proteins for seven transmembrane domain receptors. Trends Pharmacol Sci 1999; 20:184-7.
12. Kuwasako K, Shimekake Y, Masuda M, Nakahara K, Yoshida T, Kitaura M et al. Visualization of the calcitonin receptor-like receptor and its receptor activity-modifying proteins during internalization and recycling. J Biol Chem 2000; 275:29602-9.
13. Armour SL, Foord S, Kenakin T, Chen WJ. Pharmacological characterization of receptor-activity-modifying proteins (RAMPs) and the human calcitonin receptor. J Pharmacol Toxicol Meth 1999; 42:217-24.
14. Christopoulos G, Perry KJ, Morfis M, Tilakaratne N, Gao Y, Fraser NJ et al. Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product. Mol Pharmacol 1999; 56:235-42.
15. Oliver KR, Wainwright A, Edvinsson L, Pickard JD, Hill RG. Immunohistochemical localization of calcitonin receptor-like receptor and receptor activity-modifying proteins in the human cerebral vasculature. J Cereb Blood Flow Metab 2002; 22:620-9.
16. Olesen J, Diener HC, Husstedt IW, Goadsby PJ, Hall D, Meier U et al. Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med 2004; 350:1104-10.
17. You J, Johnson TD, Childres WF, Bryan RM Jr. Endothelial-mediated dilations of rat middle cerebral arteries by ATP and ADP. Am J Physiol 1997; 273:H1472-7.
18. Bryan RM Jr, Eichler MY, Swafford MW, Johnson TD, Suresh MS, Childres WF. Stimulation of alpha 2 adrenoceptors dilates the rat middle cerebral artery. Anesthesiology 1996; 85:82-90.
19. Williamson DJ, Hargreaves RJ, Hill RG, Shepheard SL. Intravital microscope studies on the effects of neurokinin agonists and calcitonin gene-related peptide on dural vessel diameter in the anaesthetized rat. Cephalalgia 1997; 17:518-24.
20. Petersen K, Dyrby L, Williamson DJ, Edvinsson L, Olesen J. Effect of hypotension and carbon dioxide changes in an improved genuine closed cranial window rat model. Cephalalgia 2005; 25:23-9.
21. Edvinsson L, Ekman R, Jansen I, McCulloch J, Uddman R. Calcitonin gene-related peptide and cerebral blood vessels: distribution and vasomotor effects. J Cereb Blood Flow Metab 1987; 7:720-8.
22. Goadsby PJ, Edvinsson L, Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 1990; 28:183-7.
23. Goadsby PJ, Edvinsson L. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 1993; 33:48-56.
24. Edvinsson L, Goadsby PJ. Neuropeptides in headache. Eur J Neurol 1998; 5:329-41.
25. Lassen LH, Haderslev PA, Jacobsen VB, Iversen HK, Sperling B, Olesen J. CGRP may play a causative role in migraine. Cephalalgia 2002; 22:54-61.
26. Juul R, Aakhus S, Bjornstad K, Gisvold SE, Brubakk AO, Edvinsson L. Calcitonin gene-related peptide (human alpha-CGRP) counteracts vasoconstriction in human subarachnoid haemorrhage. Neurosci Lett 1994; 170:67-70.
27. Jansen-Olesen I. Human cranial arteries, an in vitro model of migraine. In: Moskowitz MA, Olesen J, editors. Experimental headache models. Philadelphia: Lippencott-Raven, 1995.
28. Edvinsson L, Cantera L, Jansen-Olesen I, Uddman R. Expression of calcitonin gene-related peptidel receptor mRNA in human trigeminal ganglia and cerebral arteries. Neurosci Lett 1997; 229:209-11.
29. Edvinsson L, Hara H, Uddman R. Retrograde tracing of nerve fibers to the rat middle cerebral artery with true blue: colocalization with different peptides. J Cereb Blood Flow Metab 1989; 9:212-8.
30. Edvinsson L, Mulder H, Goadsby PJ, Uddman R. Calcitonin gene-related peptide and nitric oxide in the trigeminal ganglion: cerebral vasodilatation from trigeminal nerve stimulation involves mainly calcitonin gene-related peptide. J Auton Nerv Syst 1998; 70:15-22.
31. Goadsby PJ. Inhibition of calcitonin gene-related peptide by h-CGRP(8-37) antagonizes the cerebral dilator response from nasociliary nerve stimulation in the cat. Neurosci Lett 1993; 151:13-6.
32. Jansen I, Uddman R, Hocherman M, Ekman R, Jensen K, Olesen J et al. Localization and effects of neuropeptide Y, vasoactive intestinal polypeptide, substance P, and calcitonin gene-related peptide in human temporal arteries. Ann Neurol 1986; 20:496-501.
33. Williamson DJ, Hargreaves RJ, Hill RG, Shepheard SL. Sumatriptan inhibits neurogenic vasodilation of durai blood vessels in the anaesthetized rat-intravital microscope studies. Cephalalgia 1997; 17:525-31.
34. Akerman S, Williamson DJ, Kaube H, Goadsby PJ. Nitric oxide synthase inhibitors can antagonize neurogenic and calcitonin gene-related peptide induced dilation of dural meningeal vessels. Br J Pharmacol 2002; 137:62-8.